Looking Ahead The increasing popularity of GLP-1 agonists outside traditional diabetic populations means emergency physicians will continue to see complications from these agents
It also increases the likelihood of craving sugary, high-carb snacks to compensate for low energy
GLUCAGON-LIKE PEPTIDE-1 As discussed earlier, glucagon is known to promote hyperglycemia and it seems counterintuitive to use it as treatment in those with diabetes
BPC157 has demonstrated an exceptional safety profile across multiple studies with no evidence of organ toxicity, mutagenicity, or carcinogenicity. Sikiric et al., Journal of Physiology and Pharmacology Long-Term Safety and Human Use Although human clinical trials are limited, the peptide has been used extensively in animal models and self-experimentation circles with no long-term complications reported
Skipping site rotation is perhaps the most common long-term mistake, leading to tissue damage that eventually requires switching medications or taking extended breaks
If you have an emergency please call911 or go to the nearest urgent care facility.